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Abstract
Mitotic death is a delayed response of p53 mutant tumours that are resistant to genotoxic damage.
Questions surround why this response is so delayed and how its mechanisms serve a survival
function. After uncoupling apoptosis from G1 and S phase arrests and adapting these checkpoints,
p53 mutated tumour cells arrive at the G2 compartment where decisions regarding survival and
death are made. Missed or insufficient DNA repair in G1 and S phases after severe genotoxic
damage results in cells arriving in G2 with an accumulation of point mutations and chromosome
breaks. Double strand breaks can be repaired by homologous recombination during G2 arrest.
However, cells with excessive chromosome lesions either directly bypass the G2/M checkpoint,
starting endocycles from G2 arrest, or are subsequently detected by the spindle checkpoint and
present with the features of mitotic death. These complex features include apoptosis from
metaphase and mitosis restitution, the latter of which can also facilitate transient endocycles,
producing endopolyploid cells. The ability of cells to initiate endocycles during G2 arrest and
mitosis restitution most likely reflects their similar molecular environments, with down-regulated
mitosis promoting factor activity. Resulting endocycling cells have the ability to repair damaged
DNA, and although mostly reproductively dead, in some cases give rise to mitotic progeny. We
conclude that the features of mitotic death do not simply represent aberrations of dying cells but
are indicative of a switch to amitotic modes of cell survival that may provide additional mechanisms
of genotoxic resistance.
Introduction
Following severe genotoxic damage, cells undergo either
rapid or delayed death termed by Okada [1] as interphase
and reproductive deaths, respectively. Sensitive cells un-
dergo death within a few hours of genotoxic insult (if the
damage is not so enormous as to cause immediate necro-
sis), whilst damage resistant cells execute death after a
delay, precipitating either from the initial G2 arrest or af-
ter a number of cell divisions. In lymphoid and myeloid
cell lines, all three types of cell death require new protein
synthesis and exhibit the DNA ladder characteristic of
apoptosis [2].
This delayed reproductive death, also known as "mitotic
death", is characteristic of many p53 mutated tumours
that are resistant to genotoxic insult [3,4,5]. The main
features of mitotic death have been described by several
workers [6,7,8]. They include (a) the absence/delay of
the G1/S checkpoint and hence (b) the absence of inter-
phase apoptosis coupled to this checkpoint; (c) delay in
the G2 compartment followed by its adaptation and
hence (d) a sequence of aberrant mitoses which end in
mitotic death; (e) formation and disintegration of (multi-
nuclear) giant cells (which is often also termed mitotic
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death or catastrophe); (f) delayed apoptosis; and (g) fi-
nally survival.
Given this elaborate sequence of events associated with
resistance to genotoxic insult and poor oncological prog-
nosis [9], it is logical to suggest that these phenomena
may contribute to cell survival. To assess this possibility,
we must first explore the various facets of mitotic death.
Uncoupling of apoptosis
Terminal cell death ends any potential for repair or prop-
agation of a cell population and so the earlier death oc-
curs in the cell cycle following damage, the smaller the
potential for possible cell survival. From studies of p53,
the concept that there is a temporal element to the adap-
tive response of the cell to damage has emerged, and it
has been suggested that there is a "race between repair
and cell death" [10]. Therefore, it is clear that to ensure
genomic integrity, apoptosis should be tightly coupled to
cell cycle checkpoints and initiated rapidly [11,12]. For
this reason, apoptosis is mostly precipitated from the
G1/S checkpoint in normal, healthy, p53 wild-type cells
before segregation of genomes occurs, preventing any
chance of potentiating or fixing the damage later in the
cell cycle. As such, maintaining genome fidelity puts a
tight limit on the proliferative and survival capacity of
cells. Conversely, uncoupling cell death from cell cycle
checkpoints and delaying the terminal effector stage of
apoptosis should give cells a greater chance for repair, di-
versification of pathways and survival. This latter situa-
tion is observed in resistant tumours, where G1/S and S-
phase checkpoints fail [13] and where mitotic death is in-
itiated only at the last stage of the cell cycle, as the term
suggests, around the final stages of mitosis. The tight
negative correlation between delayed apoptosis and re-
lease from G2 arrest in p53 mutant tumours after irradi-
ation (Cragg et al., submitted), and other data [7,14,15]
suggest that the main decision for death versus survival
originates from the G2/M checkpoint. Thus, reaching the
G2 compartment would appear crucial for cell survival
and removing preceding checkpoints should increase re-
sistance. Importantly however, these resistant cells have
missed the chance of repair in G1 and S.
Repair of DNA strand-breaks
To repair damaged DNA, the damage must first be
sensed. The precise mechanisms for this are not yet
clear, although some current data suggests that p53 itself
[16] and repair proteins of the Rad 9 and Ku group, also
function as damage sensors [4,17]. Recent evidence also
indicates that in S-phase, sensing and repair of strand-
breaks competes with continued DNA replication.
Therefore, it may be that in resistant tumour cells, dam-
age is not repaired because it not sensed [18]. In support
of this notion, comparing S-phase delay for a panel of
lymphoid cell lines after a single dose of irradiation, the
most radioresistant cells delay least in S-phase and ex-
hibit the most extensive chromosomal aberrations
(Cragg et al; submitted). This situation is exacerbated by
the fact that conversion of single-strand breaks (SSB)
into pernicious double-strand breaks (DSB) and the er-
ror-prone trans-lesion DNA synthesis, are probably oc-
curring in this environment [4,19]. It is paradoxical then,
that unlike p53 mutated cells, p53 wild-type cells which
sense DNA damage and delay for repair in G1 and S, do
not recover from large genotoxic insults [20].
Potentially lethal DSB are repaired by non-homologous
end-joining (NHEJ) in G1/early S and by homologous re-
combination (HR), in late S/G2 [18,21]. NHEJ is by def-
inition error-prone and so error-free repair is only
possible through HR. Reaching the G2 compartment
provides the best chance for error-free DNA repair with-
in the mitotic cycle.
Delay in G2 – a rescue compartment?
Cells with DSB arrest in G2 at the G2/M DNA damage
checkpoint [22] and attempt HR. In fact, it was only re-
cently discovered that HR acts in human cells [18,23].
This HR repair capacity seems to be many-fold more ac-
tive in p53-mutated tumours than in wild-type counter-
parts [24] and therefore, G2 arrest should be considered
an important rescue compartment for damage-resistant
tumours. In support of this, the ability of various tumour
cell lines to accumulate after damage in G2 seems pro-
portional to their clonogenicity (Cragg et al., submitted)
and resistance to multiple anticancer drugs [14], whilst
abrogation of G2-arrest potentiates cell death [15]. This
type of response, providing maximal accumulation of
cells in G2, is due to loss of functional p53 [3,13,25] and
perhaps explains why mutations in p53 are selected for
during tumour progression.
Although possibly elevated in p53-mutated tumours, it is
clear that the repair capacity of the G2 compartment can-
not be limitless. If the damage is too extensive and the
cells have overcome (adapted) the G2/M checkpoint, the
mitoses that ensue are aberrant due to the genome insta-
bility and chromosome breaks. In addition, the ability of
chromosomes to stick at breakage sites is often displayed
in sequential post-damage mitoses as "bridge-break-fu-
sion" events and it is mostly this process which accounts
for a large proportion of first aberrant and then lethal
mitoses. All of these facets are due to secondary DNA
damage events and represent the "cost" of reaching the
G2 compartment. Several investigators have now shown
that secondary chromosome lesions and mis-repair di-
rectly cause chromosome breaks and evoke "mitotic ca-
tastrophe" [2,26,27,28,29].Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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Mitotic catastrophe
There are very diverse descriptions of mitotic catastro-
phe. Initially, mitotic catastrophe was associated with in-
complete DNA synthesis and premature chromosome
condensation [30,31], with features in common with ap-
optosis. Other authors define it as an aberrant form of
mitosis associated with the formation of multinucleate
giant cells that are temporarily viable but reproductively
dead [11,32]. Still others state that mitotic catastrophe is
pre-determined in G2 and characterised by an abortive
short cut into metaphase arrest [33,34]. Mitotic failure
often manifests with micronucleation [35,36] and nucle-
ar segmentation [37] and this in turn, is associated with
mitosis restitution into interphase polyploid cells [38].
An apoptosis-like, TUNEL-positive death from met-
aphase-arrest can often be observed in tumours after
various apoptogens [37]. It frequently accompanies mi-
tosis restitution [39], and is commonly seen during the
development of micronuclei and nuclear segments,
which are themselves initially TUNEL-negative [40,41].
Clearly, the features of mitotic catastrophe are eclectic
[39]. In fact, although these events are usually viewed as
deviations from the normal cell cycle, they involve phe-
nomena that are not necessarily associated with mitosis,
such as micronucleation, restitution, and polyploidy. In-
deed, the last of these is clearly associated with the endo-
cycle, and we would suggest that initiating the endocycle
provides an alternative to mitotic catastrophe in resist-
ant cells.
Endopolyploid giant cells
Polygenomic giant cells can arise from G2 arrested cells
[7,42,43], by cell fusion or by mitotic restitution
[38,44,45]. In all cases, tetraploidy appears to be a pre-
requisite for initiation of endocycles. True endopoly-
ploids contain several chromosome sets and are usually
formed in a series of restitution cycles by (polyploidis-
ing) mitoses, which are aborted after segregation of sis-
ter chromatids. These cells are thought to be able to
return to the diploid state either through mitosis omit-
ting S-phases or by multipolar mitosis [46]. Interesting-
ly, studies on human megakaryocytes in culture [47]
showed that 8N-16N giant nuclei express cyclin B1 and
that this co-precipitates with H1 histone kinase activity.
Thus, these nuclei retain competency for mitosis and
subsequently, multipolar mitoses with centrosomes co-
localized with cyclin B follow. For the S-phase 16N-32N
cells and for 32N and 64N cells, these activities are
strongly reduced. These data are in line with numerous
reports that 8N-ploidy represents a general limit, above
which cells cannot execute mitosis. 16N-32N cells and
cells of higher ploidy are usually unable to divide by mi-
tosis, and therefore belong to the so-called hyperploid
class of polyploids [44].
Hyperploidy, which can reach very high DNA content
values, is widely observed during the development of
transient organs in animals and plants [44,46,48]. Un-
like in true endopolyploids, in hyperploid cells, sister
chromatids usually do not become separated after repli-
cation rounds [44,46,48] and especially if slightly con-
densed, retain partial cohesion at highly reiterated sites.
Most likely, such a polytenic kind of endopolyploidy aris-
es initially from cells arrested in the G2/M or spindle
checkpoint and renders these nuclei unable to segregate
chromosomes by mitosis.
Although mostly reproductively dead, these cells howev-
er, can also return to the diploid state, through a specific
kind of cell division termed de-polyploidisation, which
involves de-polytenization, somatic pairing of homologs
and subsequent reduction divisions [44]. Such a process,
termed also "meiosis without karyogamy", has been de-
scribed by Grell in Culex [49] and in the asexual life-cycle
of Radiolaria, reviewed in [50]. Although somatic reduc-
tion is likely to occur in higher plants, the possibility of a
similar process occurring in mammalian cells remained
until recently only speculation [42,44].
In malignant tumours, there is often a population of cells
with a DNA content above the diploid value of the so-
called stem-line and in many cases a number of high-
ploidy cells are evident [51]. The proliferative potential of
this latter population remains controversial. Some au-
thors claim that high ploidy cells have reduced prolifera-
tive potential [52] or even none at all [53,54]. Others
have found that although these cells are usually delayed
in, and often deleted from, metaphase, they can prolifer-
ate either normally [55] or through multipolar mitoses
[56], although these observations may refer only to oli-
goploid tumour cells. We have observed giant cells of
8N-128N and more, as a transient response of p53 mu-
tated human lymphoma cell lines to genotoxic damage or
spindle poisons. Within this response, some endopoly-
ploid cells appear to undergo somatic reduction and/or
multipolar mitoses and produce mitotic descendants
[[41,57], also unpublished]. Therefore, it is important to
consider how endopolyploids originate from, and return
to, the mitotic cycle, with respect to the different molec-
ular environments required.
Molecular machinery of the endocycle
The mitotic cycle is dependent upon the action of the mi-
tosis-promoting factor (MPF), which is a complex of cy-
clin B and cdc2 kinase (p34 cdk1). The MPF
phosphorylates various substrates including MAPs, lam-
ins, and histone HI, which subsequently induce the spin-
dle assembly, breakdown of nuclear envelope, and
chromosome condensation, necessary for mitosis. In
contrast, lack of MPF activity and inability to execute mi-Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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tosis is considered a hallmark of the endocycle [8,42,58].
A recent study of reprogramming the cell cycle for en-
doreduplication in rodent trophoblast cells has shown
that the arrest of the mitotic cycle at the onset of endore-
duplication was associated with a failure to assemble the
MPF [59], at the G2/M checkpoint. The same can be
achieved by inhibiting cdc2 activity with the kinase in-
hibitor, staurosporine [45]. The main component of MPF
inactivity appears to be lack of nuclear cyclin B1 localisa-
tion in the endocycle [8].
For endoreduplication, DNA synthesis must occur inde-
pendently of mitosis and for this to happen several
checkpoints must be overcome. These checkpoints are
located in late S-phase (S/M [34], telophase [60], centro-
some duplication [61] checkpoints), in G2-phase (G2/M
checkpoint [22], and in M-phase (spindle and post-spin-
dle checkpoints [62,63]). In the endoreduplication cycle,
cells shuttle only between G1 and S-phase, with a trun-
cated late S-phase [8,42,44,64] and therefore many of
these checkpoints are naturally absent, allowing un-
checked DNA synthesis.
The MPF also negatively regulates the assembly of the
replication complex [8]. Stable overexpression of cyclin
E, which is part of the replication complex and the main
driver of replication, is a characteristic feature of endocy-
cling and tumour cells [8,58,60,64,65]. Therefore, it
seems likely that when DNA synthesis becomes unsched-
uled, due to the inactivity of the anaphase promoting
complex APC and the post-spindle replication check-
point, this stable and abundant cyclin E down-regulates
cdc2 kinase, and thus renders the MPF inactive, enabling
decondensation of chromosomes and reset of inter-
phase.
Most of the checkpoints detailed above are p53 depend-
ent, and so not surprisingly, the ability to initiate endo-
cycles and form endopolyploid cells is characteristic of
cells lacking wild-type p53 function [15,43,66].
Influence of DNA damage
Genotoxic damage in particular enhances this transition
from the mitotic cycle into the endocycle in p53 mutant
cells [15,66]. The arrest in the G2/M checkpoint is
known to activate chk1, which induces the phosphoryla-
tion of cdc25. This results in cdc2 remaining phosphor-
ylated on Tyr 15, causing its inactivation and through the
subsequent molecular pathway, retaining the cytoplas-
mic localisation (nuclear export) of cyclin B1 [22]. Con-
sequently, DNA damage, causing G2 arrest and
preventing MPF assembly, may provide the necessary
molecular environment to trigger entry into the endocy-
cle instead of mitosis.
Another molecular constraint to overcome, to allow en-
doreduplication, concerns the APC which couples mito-
sis to a new round of DNA replication. This function is
performed by the targeted proteolysis of several sub-
strates necessary for the completion of mitosis [62]. Ar-
rest at the spindle checkpoint caused by post-damage
secondary DNA breaks or by spindle damage, down-reg-
ulates APC activity, thus preventing exit from mitosis but
allowing entry into the endocycle by the pathways de-
tailed above [8] and in [67].
In summary, the characteristic features of p53 mutated
cancer cells in conjunction with DNA damage, appears to
facilitate the molecular environment necessary to pro-
vide a shift from mitosis into the endocycle. The main
switch-points for these transitions are outlined on Figure
1, although it should be mentioned that apoptosis repre-
sents another, third option.
Our own studies (Cragg et al., submitted) have shown
that in p53-mutated cells, the radiation dose threshold
for entering the endocycle from damage induced G2 ar-
rest is higher than for entering mitosis, and in particular,
in more resistant cells i.e. cells can still enter the endocy-
cle after high doses of irradiation. One possible explana-
tion for these data is that the endocycle provides a
survival advantage.
Can giant cells repair DNA?
If giant cells do provide a survival advantage after geno-
toxic insult, then presumably they must be able to repair
DNA. In support of this suggestion, chromatid exchang-
es have been found between sister chromatids in the en-
dopolyploid nuclei of rodent fibroblasts [68,69].
Importantly, crossing over at each site appears only to
occur between two of the many aligned chromonemes on
the multichromonemic chromosomes [70] potentially al-
lowing the production of a fully repaired chromosome.
Furthermore, some data suggest that homologous chro-
mosomes, which are randomly distributed in the mitotic
cycle of diploid cells [71], become relocated and paired in
polyploids [70,72]. This early data has acquired some re-
cent support [73] as it has been shown that homologous
chromosomes come together in generative polyploids
long before meiosis begins.
In endopolyploid tumour cells, for recombination and
somatic reduction to happen, reorganisation of endopol-
yploid nuclei should occur to provide pairing of homolo-
gous chromosomes. In support of this suggestion, a
complex somatic reduction process involving meiotic-
like bouquets has been reported recently by our group for
some Burkitt's lymphoma cell lines after high doses of ir-
radiation [41,59].Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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Although initially this process appears extremely exotic,
it has serious molecular and evolutionary grounds. An
attractive idea linking meiotic recombination with DNA
repair in somatic cells was recently proposed by Kleckner
[74] who suggested that crossing over and meiosis both
originated during evolution from the necessity to repair
DNA double strand breaks in the mitotic cycle. Further-
more, the molecular relationship between meiotic re-
combination and the mitotic DNA damage checkpoints
has now been established [75]. In addition, it is worth-
while to note that the endocycle is probably more ancient
than both meiosis and mitosis in evolution [76] and that
somatic reduction introduces elements of meiosis into
endopolyploid cells. This latter may be important, as re-
combination DNA repair by exchange between homologs
in meiosis has been reported to be up to 10 times more
effective than between sister chromatids [77].
Somatic reduction of endopolyploid cells, including pair-
ing of homologs similar to that in meiosis, may therefore
represent an effective means of both DNA repair and re-
turn to diploidy and the mitotic cycle. In fact, comparing
the efficacy of HR in different cell cycle compartments
reported in the literature, it can be inferred that HR effi-
ciency increases from G1 to G2 [78] and then still further
from G2 of the mitotic cycle to the endocycle. Possibly
therefore, in the race between DNA repair and apoptosis,
repair is elevated and apoptosis delayed further and fur-
Figure 1
The schema shows the available switchpoints from the mitotic pathway to the endocycle in p53 mutant cells and stimulation of
this switch by DNA damage. As can be seen, G2 arrested cells can go directly from the G2/M damage checkpoint into the
endocycle or go on to apoptose. However, if the G2/M checkpoint is adapted, cells can also enter into mitosis, and from there
possible arrest in metaphase. In turn, M-arrest has three alternative exits: to return to the mitotic cycle, to undergo apoptosis
or, through restitution, to enter the endocycle. Mitosis restitution is unstable and can be aborted evoking apoptosis. Endocy-
cling cells often precipitate apoptosis, but can also return through somatic reduction to the mitotic cycle. The checkpoint(s) for
this last process is unknown.Cancer Cell International 2001, 1:1 http://www.cancerci.com/content/1/1/1
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ther, allowing this extreme shift into the endocycle to oc-
cur in the most resistant tumours.
Conclusion
In conclusion, after extensive DNA damage, p53 mutated
cells miss DNA repair and apoptosis at the G1 and S
phase checkpoints and accumulate at the G2 arrest com-
partment with point mutations and chromosome breaks.
The latter exhibit at the spindle checkpoint with mitotic
catastrophe. In the absence of p53, the various phenom-
ena of mitotic death, including mitosis restitution, are
induced in an attempt to execute an evolutionarily con-
served survival program via transient endocycles. The
molecular environment of G2 arrest and restituting mi-
tosis down-regulates MPF activity allowing initiation of
the endocycle. The resulting polyploid cells may harbour
greater DNA repair capacity coupled with the potential
to return to the mitotic cycle and may therefore provide
a survival advantage.
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